Aluminium osteomalacia in chronic renal failure patients neither on dialysis nor taking aluminium containing phosphate binders

  • A. A. J. O’Brien
  • D. P. Moore
  • J. A. B. Keogh


The incidence of aluminium osteomalacia (ALO) in patients with chronic renal failure neither on dialysis nor taking aluminium-containing phosphate binders (ACPB) is not well documented. Biochemical and histological bone investigations were performed in 35 patients fulfilling the above conditions, among whom we found an incidence of ALO of 17%. In the ALO group, salient findings were PTH level (mean ± s.d.) of 3.1±1.4 ng/ml (normal <0.5 ng/ml); elevated home tap-water aluminium levels of 6.5±1.2 umol/1 (normal <2 umol/1); and a GFR of 20.5 mls/min/ 1.73m, (range 2–50 mls/min/1.73m).

We conclude that the aetiology of ALO in this group involves the absorption of toxic home water aluminium in the presence of an elevated PTH level and a GFR <50 mls/min/1.73m.


Osteomalacia Phosphate Binder Renal Osteodystrophy Chronic Renal Failure Patient Chronic Pyelonephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ward, M. K., Fest, T. G., Ellis, H. A. Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminium. Lancet 1978: 1, 841–845.PubMedCrossRefGoogle Scholar
  2. 2.
    Ellis, H. A., McCarthy, J. H., Hetherington, J. Bone aluminium in haemodialysed patients and in rats injects with aluminium chloride: relationship to impaired bone mineralisation. J. Clin. Pathol. 1979: 32, 832–844.PubMedCrossRefGoogle Scholar
  3. 3.
    Felsenfeld, A. J., Gutman, R. A., Liach, F., Harrelson, J. M. Osteomalacia in chronic renal failure; a syndrome previously reported only with maintenence dialysis. Am. J. Nephrol. 1982: 2, 147–154.PubMedGoogle Scholar
  4. 4.
    Andreoli, S. P., Bergstein, J. M., Sherrard, D. J. Alumunium intoxication from aluminiumcontaining phosphate binders in children with azotaemia not undergoing dialysis. N. Eng. J. Med. 1984: 310, 1079–1084.Google Scholar
  5. 5.
    Goldner, J. A modification of the Masson trichome technique for routine laboratory purposes. Am. J. Path. 1938: 14, 237–242.Google Scholar
  6. 6.
    Lillie, P. D., Fullmer, H. M. Histopathologic technique and practical histochemistry. McGraw-Hill, New York, 1976.Google Scholar
  7. 7.
    Mora Pataia, F. J., Ellis, H. A., Cook, D. B., Dewar, J. H., Ward, M. K., Wilkinson, R., Kerr, D. N. S. Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Q. J. Med. 1983: 207, 332–348.Google Scholar
  8. 8.
    Milliner, D. S., Nebeker, H. G., Ott, S., Andress, D. L., Sherrard, D. J., Alfrey, A. C., Slatopolsky, E. A., Coburn, J. W. Use of desferrioxamine infusion test in the diagnosis of aluminium-related osteodystrophy. N. Eng. J. Med. 1984: 101, 775–780.Google Scholar
  9. 9.
    Andress, D. L., Kopp, J. B., Maloney, M. A., Coburn, J. W., Sherrard, D., J. Early deposition of aluminium in bone in diabetic patients on haemodialysis. N. Eng. J. Med. 1987: 316, 292–296.Google Scholar
  10. 10.
    Marsden, S.N. E., Parkinson, I. S., Ward, M. K., Ellis, H. A., Kerr, D. N. S. Evidence for aluminium accumulation in renal failure. Proc, Eur. Dial. Transplant Ass. 1979: 16, 588–594.Google Scholar
  11. 11.
    Cam, J. M., Luck, V. A., Hynson, W. V. The effect of aluminium hydroxide on calcium phosphorus and aluminium metabolism in normal subjects. Clin. Sci. Mol. Med. 1976: 51, 407–414.PubMedGoogle Scholar
  12. 12.
    Berlyn, G. M., Pest, D., Ben-Ari, J., Weinberger, J., Stem, M., Gilmore, G. R., Levine, R. Hyperaluminaemia from aluminium resins in renal failure. Lancet 1970: 2, 494–496,CrossRefGoogle Scholar
  13. 13.
    Alfrey, A. C. Aluminium. Adv. Clin. Chem. 1983: 23, 69–91.Google Scholar
  14. 14.
    Ott, S. Aluminium accumulation in patients with normal renal function. Am. J. Kidney Dis. 1986: 6, 297–301.Google Scholar
  15. 15.
    Mayor, G. H., Burnatowska-Hledin, M. A. Impaired renal function and aluminium metabolism. Fed. Prod. 1983: 42, 279–283.Google Scholar
  16. 16.
    Hodsman, A. B., Sherrard, D. J., Alfrey, A. C., Ott, S., Brickman, A. S., Miller, N. L., Maloney, N. A., Cobum, J. W. Bone aluminium and histomorphometric features of renal osteodystrophy. J. Clin. Endocrinol. Metab. 1982: 54, 539–546.PubMedCrossRefGoogle Scholar
  17. 17.
    Morrissey, J., Rothstein, M., Mayor, G., Slatopolsky, E. Suppression of parathyroid hormone secretion by aluminium. Kidney Int. 1983: 23, 699–704.PubMedCrossRefGoogle Scholar
  18. 18.
    Malluche, H. H., Meyer, W., Sherman, D., Massry, S. G. Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance of iliac crest bone. Calcif. Tissue Int. 1982: 34, 449–455.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 1990

Authors and Affiliations

  • A. A. J. O’Brien
    • 1
  • D. P. Moore
    • 1
  • J. A. B. Keogh
    • 1
  1. 1.Department of Clinical MedicineMeath HospitalDublin 8

Personalised recommendations